נורוקלב 50 מג טבליות ללעיסה לחתולים וכלבים וטרינרי イスラエル - ヘブライ語 - Ministry of Health

נורוקלב 50 מג טבליות ללעיסה לחתולים וכלבים וטרינרי

comex ltd - amoxicillin as trihydrate; clavulanic acid as potassium - טבליות לעיסות - clavulanic acid as potassium 10 mg; amoxicillin as trihydrate 40 mg

פן-סטרפ 20/25 וטרינרי イスラエル - ヘブライ語 - Ministry of Health

פן-סטרפ 20/25 וטרינרי

abic veterinary products ltd - dehydrostreptomycin sulfate 250 mg/ml; procaine benzylpenicillin 200 iu/ml - solution for injection - infections due to penicillin and streptomycin sensitive microorganism.

פן וסטרפ וטרינרי イスラエル - ヘブライ語 - Ministry of Health

פן וסטרפ וטרינרי

comex ltd - dihydrostreptomycin sulfate 250 mg/ml; procaine benzylpenicillin 200 mg/ml - suspension for injection - treatment of infection caused orassociated with organisms sensitive to penicillin and/or streptomycin in cattle, horses, pigs and sheep.

נורוצילין וטרינרי イスラエル - ヘブライ語 - Ministry of Health

נורוצילין וטרינרי

comex ltd - procaine benzylpenicillin 300 mg/ml - suspension for injection - norocillin is recommended in the treatment of diseases caused by susceptible organisms to penicillin in cattle, sheep and pigs.

פן-סטרפ 2025 וטרינרי イスラエル - ヘブライ語 - Ministry of Health

פן-סטרפ 2025 וטרינרי

abic veterinary products ltd - dehydrostreptomycin sulfate; procaine benzylpenicillin - תמיסה להזרקה - procaine benzylpenicillin 200 iu/ml; dehydrostreptomycin sulfate 250 mg/ml

סינולוקס LC וטרינרי イスラエル - ヘブライ語 - Ministry of Health

סינולוקס lc וטרינרי

pfizer pharmaceuticals israel ltd - amoxicillin as trihydrate 200 mg/dose; clavulanic acid as potassium 55 mg/dose - suspension for injection - combinations - for the treatment of bovine mastitis in lactating cows. it has a broad spectrum of bactericidal activity against bacteria which are sensitive to synulox isolated from the bovine udder.

מווקס תמיסה イスラエル - ヘブライ語 - Ministry of Health

מווקס תמיסה

vitamed pharmaceutical industries ltd - bromhexine hydrochloride - תמיסה - bromhexine hydrochloride 2.00 mg/ml - bromhexine - bromhexine - bronchial mucolytic. it can also be given by inhalation as an aerosol solution.

מוקולס  תמיסה イスラエル - ヘブライ語 - Ministry of Health

מוקולס תמיסה

vitamed pharmaceutical industries ltd - bromhexine hydrochloride - תמיסה - bromhexine hydrochloride 2 mg/ml - bromhexine

ונקומיצין ויאטריס 500 מג イスラエル - ヘブライ語 - Ministry of Health

ונקומיצין ויאטריס 500 מג

genmedix , israel - vancomycin as hydrochloride - lyophilized powder for injection - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

ונקומיצין מיילן 500 מג イスラエル - ヘブライ語 - Ministry of Health

ונקומיצין מיילן 500 מג

genmedix , israel - vancomycin as hydrochloride - lyophilized powder for injection - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal